CAS NO: | 1160514-60-2 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | Pyr3 is a selective inhibitor of transient receptor potential canonical channel 3(TRPC3), with anIC50of 700 nM for TRPC3-mediated Ca2+influx. | ||||||||||||||||
IC50& Target | IC50: 700 nM (TRPC3)[1]. | ||||||||||||||||
体外研究 (In Vitro) | Pyr3 selectively and directly inhibits TRPC3 channels among TRPC family members. Application of Pyr3 inhibits TRPC3-mediated Ca2+influx in a dose-dependent manner with the IC50value of 700 nM. Pyr3 becomes apparent at 0.3 μM, and is almost complete at 3 μM. Interestingly, Ca2+influx is inhibited by Pyr3 in cells co-expressing TRPC3 plus TRPC6 but not in cells coexpressing TRPC1 plus TRPC5. The Ang II-induced NFAT translocation is suppressed by Pyr3, but weakly by Pyr2 in a concentration-dependent manner (IC50value was 0.05 μM for Pyr3 and 2 μM for Pyr2)[1]. | ||||||||||||||||
分子量 | 456.63 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H11Cl3F3N3O3 | ||||||||||||||||
CAS 号 | 1160514-60-2 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 125 mg/mL(273.74 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|